Rationale: Long-term intermittent hypoxia exposure in adult mice, modeling oxygenation patterns of moderate-severe obstructive sleep apnea, results in lasting hypersomnolence and is associated with nitration and oxidation injuries in many brain regions, including wake-active regions.
Introduction
Obstructive sleep apnea with significant sleepiness is present in at 2-4% of the adult population (1), and despite therapy, many patients with obstructive sleep apnea have small improvements in the objective measures of sleepiness (2, 3). The mechanisms of persistent sleepiness in treated sleep apnea are presently not known, but severity of oxyhemoglobin desaturations best predicts sleepiness in persons with obstructive sleep apnea (4-7).
Animal studies have been instrumental in establishing that hypoxia/reoxygenation causes both neural injury and neurobehavioral impairments including hypersomnolence (8) (9) (10) (11) (12) (13) . Long-term intermittent hypoxia (LTIH), modeling the oxygenation patterns of moderate-severe obstructive sleep apnea, results in lasting hypersomnolence, and a vast array of oxidative changes in sleep/wake brain regions (12) . Drugs that reduce the availability of superoxide free radical reduce the neural injury (9, 13) . However, wake-active brain regions of mice exposed to LTIH show evidence of both reactive oxygen and nitrogen species with the formation of nitrosylation, nitration and lipid peroxidation (12) .
Enzymes controlling the production of nitric oxide (NO•) in brain tissue, therefore, should play important roles in LTIH hypersomnolence, sleepiness and other LTIH-induced impaired neural functions. Generation of reactive nitrogen species underlies nitration of proteins (14) , and lipid peroxidation (15) , and, under specific conditions, promotes carbonylation (16, 17) . Of the nitric oxide synthase isoforms in brain tissue, inducible nitric oxide synthase (iNOS) produces large quantities of NO• that may diffuse from the extracellular matrix into neurons (18) . Moreover, iNOS has been implicated in several oxidative neurodegenerative disorders (19) (20) (21) (22) (23) (24) . However, iNOS has also been shown to contribute to hypoxia preconditioning responses in cardiac and brain tissue (25) (26) (27) , so that alternatively, iNOS could play a protective role in LTIH. Presently, it is unclear whether LTIH activates iNOS in wake-active brain regions, whether changes in iNOS activity would protect from LTIH oxidative injury and/or lessen hypersomnolence, or if iNOS activation contributes to the oxidative injuries and/or hypersomnolence.
In an effort to begin to define the mechanisms and identify potential therapeutic targets for the neurobehavioral morbidities of obstructive sleep apnea, we designed the following studies to determine what roles iNOS plays in the development of LTIH wakefulness impairments, the proinflammatory and oxidative/nitrative responses. We first determined if iNOS activation occurs in wake-active brain regions. We then compared the effects of LTIH on hypersomnolence, oxidative injury and the proinflammatory response in mice with absent iNOS to wild type controls. To complement studies performed in mutant mice, we characterized the effect of acute iNOS inhibition on the proinflammatory gene responses in wild type mice following LTIH. Long-term intermittent hypoxia protocol. A detailed description of the long-term intermittent hypoxia (LTIH) protocol was recently published (12, 13) . Briefly, an automated nitrogen/oxygen delivery profile system (Oxycycler model A84XOV; Biospherix, Redfield, NY) was used to change ambient oxygen levels from 21% to 10% for 5 sec at 90 sec intervals, resulting in arterial oxyhemoglobin saturation fluctuations for LTIH between 96-98% and 83-86% and for sham LTIH between 96-98% and 94-98%. LTIH was produced for 10 hr of the lights-on period for 6 wks.
MATERIALS AND METHODS

Animals
Humidity, ambient CO 2 and environmental temperature were held constant. cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) was performed on macropunches of selected brain regions in mice exposed to sham LTIH or LTIH, using methods as previously published (33) . Briefly, 2 wks after completion of sham LTIH or LTIH, mice were perfused with PBS; brains were immediately frozen and sectioned (300µm) for macropunches of the following brain regions: frontal cortex, magnocellular preoptic/substantia inominata/horizontal diagonal band (laterobasal forebrain), hippocampus CA1, posterior and lateral hypothalamus. RNA was purified and cDNA created for primer sets for primer/probe sets in Table 1 for Taqman real time PCR (SDS-7900HT, ABI). All primer probe sets showed excellent sensitivity and linearity (detection of 100 copies/sample, r 2 0.99).
Systemic iNOS inhibition. An additional series of mice was used to determine if LTIH gene
responses could be blocked with iNOS inhibition, following LTIH. Following LTIH exposure and 2 wks in normoxia, C57Bl/6J mice were injected with iNOS inhibitor (1400W, 0.01, 0.1, 1 or 2 mg/kg subcutaneously) or saline (vehicle) every 12 hrs for three doses (n=2-6/dose/condition, allowing n=18 for correlation for each region). Linear regression was performed using within mouse % iNOS inhibition (forebrain) vs. copy numbers of TNF-and COX-2 (basal forebrain and posterior/lateral hypothalamus). (35) Thin layer chromatography was used for purification of the eluate, and negative ion chemical ionization gas chromatography-mass spectrometry was used to assay F 2 -iPs (36).
Statistical Analysis.
Values reported represent mean ± SEM. Parameter differences were analyzed with one and two-way ANOVA, with LTIH conditions, brain region, strain or drug treatment as the independent variables. When significant overall differences were observed, a priori within group comparisons of means were performed using Bonferroni post-tests for pre-selected groups. The null hypothesis was rejected for Bonferroni-corrected probabilities <0.05.
Results
LTIH increases iNOS activity in two representative wake-active regions, the laterobasal forebrain
and posterior/lateral hypothalamus. There were no differences in total NOS activity (expressed as min, t=3.4, p<0.05) and an even larger difference in sleep latencies was observed for the null mice after 6 hr forced wakefulness (mean difference -4 min, t=5.9, p<0.001). LTIH in wild type mice resulted in a shortened sleep latency (-3 min, t=4.1, p<0.001), and a significant reduction in the sleep latency after 6 hr forced wakefulness (mean difference -6 min, t=7.5, p<0.001). In contrast, LTIH had no significant effect on either the baseline (mean difference -1 min, t=1.7) or sleep deprivation sleep latencies (mean difference 0 min, t=1.8). Based on sample size, means and deviations observed in sham LTIH iNOS-/-mice, the experiment was adequately powered (>.85) to detect a two-way 3 min change in sleep latency for both baseline and forced wakefulness conditions. LTIH had no effect on average duration of wake or sleep bouts, arousal index or REM sleep latencies in the iNOS null mice, while wake bouts shortened in the wild type mice exposed to LTIH (mean difference 3 min, t=5.8, p<0.01).
Effects of iNOS absence on the long-term hypoxia/reoxygenation proinflammatory gene expression.
Proinflammatory gene expression (TNF-, COX-2 and iNOS) was measured in four brain regions with LTIH increased p67 phox gene expression (cortex, lateral basal forebrain, hippocampus CA1, and lateral hypothalamus) in iNOS-/-and +/+ mice exposed to LTIH or sham LTIH (n=15, each group), using 20 µg of the same purified RNA sample obtained from each mouse for each region.
Values are presented in Fig. 3 .
Overall, large effects of LTIH and genotype were observed for TNF-mRNA (F=1500, p<0.0001). In wild type mice, LTIH was associated with increased TNF-mRNA in all four brain regions, p<0.05 (see Fig. 3A ), while in iNOS -/-mice, LTIH increases in TNF-were observed only in the lateral basal forebrain and Ca1 hippocampus, p<0.05. Cortical TNF-gene levels in LTIH exposed mice were significantly higher in wild type mice than in iNOS-/-mice, t=14, p<0.001.
In response to LTIH, COX-2 gene expression was increased in brains of both iNOS-/-and wild type mice (F=30, p<0.01), as summarized in Fig. 3B . LTIH increases in wild type mice were found in cortex (Bonferroni t=3.5, p<0.05) and in lateral basal forebrain (Bonferroni t=3.4, p<0.01).
Increases in iNOS mutant mice were also observed in the cortex and laterobasal forebrain (t=3.1, 3.3, p<0.05), but the LTIH effect was of less magnitude than in wild type mice cortex and lateral basal forebrain than the iNOS +/+ mice exposed to LTIH, as shown in Fig. 3 . COX-2 gene expression following sham LTIH did not vary significantly with strain in any region.
Large increases were observed in iNOS gene expression response to LTIH in iNOS null mice, (F=334, p<0.001). In the iNOS -/-mice, large increases were observed in each brain region assayed in response to LTIH (Fig. 3C , t's=5-13, p<0.01). In contrast, there was no LTIH on iNOS copy numbers in wild type mice, except in the posterior and lateral hypothalamus.
Lack of iNOS activity confers resistance to long-term intermittent hypoxia-induced oxidative protein
damage in lateral basal forebrain. Isoprostane levels measured in dissected lateral basal forebrain tissue blocks from iNOS -/-and +/+ mice exposed to LTIH or sham LTIH (n=6/strain and condition). IPF 2 Sham LTIH levels did not vary with strain (Fig.5A) . IPF 2 levels in wild type mice were increased compared to sham LTIH (F=65, p<0.01), and did not increase signficantly in iNOS mutants across LTIH conditions, N.S.). A separate group of mice were used for carbonyl protein measurement. Macrodissections of the lateral basal forebrain were obtained from iNOS -/-and +/+ mice exposed to LTIH or sham LTIH (n=10-11/strain and condition). Carbonyl content in the two sham LTIH groups was lower in iNOS -/-mice compared to +/+ mice, p <0.05 (Fig. 4B) . Both wild type, t=3.9, p<0.05, and mutant mice =3.2, p<0.05, showed increases in carbonyl content with LTIH.
Effects of iNOS inhibition on proinflammatory gene responses and iNOS activity following LTIH.
Systemic injection of iNOS inhibitor 1400W significantly reduced iNOS activity for doses of 1 and 2 mg/kg, F=84, p<0.01. Overall, there was a dose-dependent response in iNOS activity across the 5 doses (r 2 = 0.75). There were significant effects of iNOS inhibition on the proinflammatory gene responses of TNF-and COX-2, as shown in Fig. 5 . In the lateral basal forebrain, the goodness of fit for TNF-vs. %iNOS inhibition was r 2 = 0.44, F=13, p<0.003, and in the LH/PH the goodness of fit for TNF-vs. %iNOS inhibition was r 2 = 0.7, F=38, p<0.0001. In the lateral basal forebrain, the goodness of fit for COX-2 vs. %iNOS inhibition was r 2 = 0.55, F=22, p<0.001, and in the LH/PH the goodness of fit for COX-2 vs. %iNOS inhibition was r 2 = 0.60, F=27, p<0.0001.
DISCUSSION
Results from this collection of studies advance our understanding of the mechanisms through which long-term intermittent hypoxia (LTIH) results in lasting hypersomnolence and sleepiness. Transgenic absence of iNOS confers resistance to the recently described LTIH-induced wake impairments (8) . In addition, transgenic absence of iNOS is associated with a blunting of the LTIH-induced proinflammatory gene responses in the cortex and lateral basal forebrain. Mice without functional iNOS were resistant to the LTIH-increase in lipid peroxidation. In contrast, there was no strain effect observed for the LTIH effect on carbonyl content. In wild type mice, iNOS inhibition was effective in reversing the LTIH proinflammatory gene response. Together, these data show that iNOS activity is necessary for not only LTIH hypersomnolence, but it also contributes, in part, to the proinflammatory gene response and lipid peroxidation in mice. In addition, it is possible to reverse the LTIH proinflammatory response with iNOS inhibition.
Methodological considerations
The presented studies implemented an established murine model of the hypoxia/reoxygenation patterns observed in persons with severe obstructive sleep apnea (10, 12, 37 
Long-term intermittent hypoxia results in lasting increases in iNOS activity in wake-active regions. LTIH resulted in increased iNOS activity in brain regions tested. INOS protein is increased
in palatine tissue in persons with obstructive sleep apnea (39); however, iNOS activity in sleep apnea has not been reported. Acute hypoxia increases iNOS through HIF-1 binding to the iNOS promoter and/or NFK-B activation of p38 MAPK (40) (41) (42) (43) (44) (45) . Two wks IH results in elevated iNOS activity in the cortex (46) . We extend the characterization to show that iNOS activity is elevated two wks after LTIH in the lateral basal forebrain and hypothalamic wake-active regions. Our iNOS inhibition trials show that this elevated iNOS activity is, at least in part, responsible for the LTIH proinflammatory response. Whether this persistent increase in iNOS activity contributes to the persistence of wake impairments and whether iNOS inhibition following LTIH would facilitate recovery of neural function should now be studied.
The increase in iNOS activity without a change in total NOS activity suggests that one or more of the other NOS isoforms are reduced in LTIH. One of the other major isoforms in neural tissue is neuronal NOS (nNOS) (47) . The present work raises the possibility that nNOS activity is reduced in LTIH. Neuronal NOS in cholinergic neurons may contribute to wakefulness and REMS through enhanced cholinergic neural transmission (48, 49) . Thus, LTIH induced reduction in nNOS activity should be explored as a potential mechanism through which LTIH induces hypersomnolence.
Transgenic absence of iNOS activity confers a resistance to LTIH hypersomnolence, sleepiness, oxidative changes and the proinflammatory response. Mice with a transgenic absence of the ability to induce iNOS synthesis are resistant to LTIH hypersomnolence. Lack of effect on sleep times may not be attributed to a ceiling effect from higher baseline total sleep times in the mutants, because sleep in the mutants did increase after sleep loss (data not shown). Unlike wild type mice, LTIH did not result in shortened wakefulness bouts in iNOS -/-mice or shorter sleep latencies. Thus, all known LTIH-induced wake impairments are iNOS-dependent processes.
Whether iNOS impairs wakefulness through neural injury or nitration/nitrosylation signaling mechanisms is presently unknown.
LTIH resulted in a proinflammatory gene response in many brain regions. Magnitudes of gene responses varied with the gene assayed, the regions sampled and iNOS strain. Of particular interest, an LTIH TNF-gene response was evident in wild types in all brain regions tested, while COX-2 mRNA was increased only in the lateral basal forebrain and cortex. The cDNA's for TNF-a and COX-2 were created from the same purified RNA samples; thus, the difference cannot be explained by sampling quality differences. The magnitude of increase in COX-2 mRNA in LTIHexposed cortex tissue (2.5-fold) is consistent with a previous studies immediately after shorter IH in rats (10). COX-2 up regulation in the brain results in prostaglandin E 2 synthesis and oxidative injury (50) and is implicated in the pathogenesis of several neurodegenerative disorders, including
Parkinson's and Alzheimer's (51, 52) . The reported regional differences in COX-2 gene responses must be confirmed with enzymatic activity.
The increase in iNOS mRNA levels in iNOS-/-mice in response to LTIH is of particular interest. The mutant mouseline used in our studies has a replacement of the calmodulin binding domain with a neomycin gene; the resultant effect of this transgene is complete loss of inducibility for iNOS, i.e., no iNOS protein (28) , but this will not effect transcription of the gene, and the gene is otherwise intact. Transcriptional regulation of the iNOS gene is complex, and regulated by cytokines, a hypoxia responsive enhancer element, and SAPK/JNK and p38a MAPK (53, 54) . In addition, changes in iNOS mRNA stability have been reported, and it is possible that the increase we observe is, in part, a consequence of increased stability. For example, -adrenergic stimulation enhances the IL-1b induction of iNOS, in part through mRNA stabilization (55) . Thus, there are many potential reasons for why LTIH increased iNOS mRNA in the mutant mice, and we will need to systematically explore these to determine the mechanisms through which LTIH increases iNOS.
High levels of iNOS mRNA in iNOS-/-mice in response to LTIH suggest to us that the iNOS protein itself must provide a negative feedback to transcription or mRNA stability that we have unmasked in this model.
Transgenic absence of iNOS prevented significant lipid peroxidation within the brain and brainstem of mice exposed to LTIH. Inducible NOS has been shown to contribute to the formation of peroxynitrite (ONOO-) in brain lipid peroxidation (56) . Lower isoprostane levels (lipid peroxidation) in LTIH-exposed iNOS null mice, relative to controls exposed to LTIH, suggests that iNOS activity is necessary for LTIH-induce isoprostane formation. Whether long-term iNOS inhibition after LTIH can reverse lipid peroxidation should be addressed. The reduction in sham LTIH protein carbonylation in iNOS null mice surprised us, but has been shown in a lung injury model using iNOS null mice (57) .
In the present study, we have characterized the overall role for iNOS in LTIH as injurious,
by showing iNOS-dependence in all known LTIH wake impairments, oxidative injury and the proinflammatory gene response. Dose-dependent effects of iNOS inhibition on sleep/wake activity and on LTIH injury and hypersomnolence must now be tested. Whether longer-term iNOS inhibition of the LTIH proinflammatory gene response would be followed by reductions in oxidative injury and improved reversal of hypersomnolence will be important to ascertain, as we look to develop therapeutics to lessen residual hypersomnolence in persons treated for sleep apnea. 
